Editor’s Choice for May 2018
Published: 21 May 2018
Views: 1279
Prof Gordon McVie - Founding Editor, ecancer
- Categories:
- Brain & nervous system
- Breast
- Melanoma & skin
- Neuroendocrine
- Ovary & gynaecology
- Prostate & urology
- Nutrition & wellbeing
- Patient empowerment
- Personalised medicine
- Psychosocial
- Care
- Economics
- Low-middle income
- Medicines
- Organisation of cancer
- Prevention
- R&D
- Regulatory
- Science domains
- Social determinants
- Technology & innovation
- Training & development
- Bioinformatics
- Biology
- Biomarkers
- Causes of cancer
- Control, survivorships & outcomes
- Detection, diagnosis & prognosis
- Diagnostics
- Epidemiology & prevention
- Antibodies & immunotherapy
- Cell therapy & stem cells
- Complications
- Cytotoxics
- Drug development
- Hormones/endocrine
- Radiotherapy
- Supportive care
- Surgery
- Targeted molecules
- Vaccines & virus
Related Videos
COVID-19: Management of non-small cell lung cancer patients during the coronavir...
Dr Heather Wakelee - Stanford University, Stanford, USA
12 May 2020
Advances in breast cancer treatment over the last 20 years
Dr Philip Poortmans - Institut Curie, Paris, France
27 Jan 2020
Melanoma highlights from ESMO 2019
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
30 Sep 2019
How will ASCO combat cancer disparities?
Dr Eduardo Cazap, Dr Richard Schilsky
21 Jun 2019
The global program of the American Cancer Society
Dr Meg O'Brien - American Cancer Society, Atlanta, USA
5 Jun 2019
Latest in ovarian cancer treatment
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
24 May 2019
ASCO GU 2019 renal highlights
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
14 Feb 2019
Multiple myeloma highlights and more from ASH 2018
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
3 Dec 2018
21st century medicine is transforming healthcare and the diagnosis and treatment...
Dr Leroy Hood - Institute For Systems Biology, Seattle, USA
9 Jul 2018
